NKGen Biotech, Inc. (NKGN)
OTCMKTS · Delayed Price · Currency is USD
0.0101
-0.0499 (-83.17%)
Jul 30, 2026, 3:42 PM EST
NKGen Biotech Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
26
Market Cap
1.32M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | 77.00K | -349.00K | -81.92% |
| Dec 31, 2021 | 426.00K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionNKGen Biotech News
- 4 weeks ago - NKGen Biotech to Present at the 2026 BIOCHINA Global Forum on Troculeucel's Potential in Alzheimer's Disease and Other Neurodegenerative Conditions - GlobeNewsWire
- 2 months ago - NKGen Biotech Expands Clinical Trial Site Network for Alzheimer's Disease Program Across U.S. to Improve Patient Access and Support Enrollment - GlobeNewsWire
- 4 months ago - NKGen Biotech to Present Troculeucel Mechanism Data in Alzheimer's and Frontotemporal Dementia at the Neuroimmunology Drug Development Summit - GlobeNewsWire
- 4 months ago - NKGen Biotech Reports Combined Phase 1 Troculeucel Data Demonstrating Dose-Responsive Cognitive Improvements and Biomarker Correlations in Alzheimer's Disease at AD/PD 2026™ - GlobeNewsWire
- 5 months ago - NKGen Biotech to Present Integrated Phase 1 Clinical and Biomarker Analyses for Troculeucel in Alzheimer's Disease at AD/PD™ 2026 - GlobeNewsWire
- 6 months ago - NKGen Biotech appoints Bruce Miller to Scientific Advisory Board - TheFly
- 6 months ago - NKGen Biotech Names Leading Dementia Expert Bruce L. Miller, M.D. - GlobeNewsWire
- 8 months ago - NKGen Biotech issues statement on NKGen Korea board appointments - TheFly